NPPNY Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 birž. 2024 @ 20:05):
No signals from the correlation tool

Stats
Šios dienos apimtis	2 387
Vidutinė apimtis	523
Rinkos kapitalizacija	1.35B
EPS	$27.45 ( Q4 \| 2024-03-31 )
Kita pelno data	( $0 ) 2024-08-08
Last Dividend	$0.105 ( 2022-09-29 )
Next Dividend	$0 ( N/A )
P/E	8.33 (Sector) 0 (Industry) 0
ATR14	$0 (0.00%)

ACRDF 0.00%

ACRHF 0.00%

APNHY 0.00%

AVTBF 0.63%

AYRWF -14.89%

BBBT 0.00%

BLMS -9.09%

CBDHF 0.00%

CBGL 0.00%

CCHWF -21.71%

CENBF 0.00%

CHALF -99.00%

CNTTQ 0.00%

CRLBF -11.73%

CRYM -1.48%

DVAXW 9 900.00%

DVLP 0.00%

EAPH 12.03%

EDXC 55.17%

EMHTF 0.00%

ESALF -2.11%

ESALY 12.50%

ETST 11.90%

GDNSF -3.00%

GLASF 0.00%

GNHAY -15.36%

GRAMF 9 900.00%

HCANF 0.00%

HKMPY 0.00%

HLUYY 0.00%

HYEX -1.11%

HYPMY 0.00%

IPSEY 1.06%

ITHUF -18.67%

JUSHF 20.00%

KGKG 0.00%

LOWLF 0.00%

LVRLF 0.00%

MILC -1.14%

MKKGY -66.67%

NLBS 0.00%

NPHC 0.00%

NPPNY 0.00%

NUNZ 7.50%

ORXOY 2.13%

PLNHF 0.00%

PZOO -26.83%

RLBD 1.82%

RWBYF 0.21%

SGIOY 0.00%

TAIPY -12.10%

TCNNF 0.00%

TEVJF 0.00%

TLGTQ -11.79%

TRSSF -7.41%

UNRV -2.59%

VEXTF -13.10%

VLNCD 0.00%

VRNOF 0.00%

Koreliacija (AI algo v.1.1b): Paired value (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Nippon Shinyaku Co., Ltd. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Nippon Shinyaku Co., Ltd. Finansinės ataskaitos

Annual	2024
Pajamos:	$148.26B
Bruto pelnas:	$97.02B (65.44 %)
EPS:	$383.82

FY	2024
Pajamos:	$148.26B
Bruto pelnas:	$97.02B (65.44 %)
EPS:	$383.82

FY	2023
Pajamos:	$144.18B
Bruto pelnas:	$88.20B (61.17 %)
EPS:	$338.70

FY	2022
Pajamos:	$137.48B
Bruto pelnas:	$87.29B (63.49 %)
EPS:	$370.97

Financial Reports:

No articles found.

Nippon Shinyaku Co., Ltd. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.105 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Nippon Shinyaku Co., Ltd. Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.47 - Stable (29.33%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0575	2017-10-02
Last Dividend	$0.105	2022-09-29
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	11	--
Total Paid Out	$1.029	--
Avg. Dividend % Per Year	0.00%	--
Score	4.09	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.47
Div. Directional Score	9.92	--

Next Divdend (Est)
(2024-10-23)

$0 Estimate 0.00 %

Dividend Stability

0.08 Very Bad

Dividend Score

4.09

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
29 Sep 2022	$0.105	30 Nov -0001	30 Nov -0001	30 Nov -0001
29 Mar 2022	$0.108	30 Nov -0001	30 Nov -0001	30 Nov -0001
28 Sep 2021	$0.112	30 Nov -0001	30 Nov -0001	30 Nov -0001
29 Mar 2021	$0.113	30 Nov -0001	30 Nov -0001	30 Nov -0001
28 Sep 2020	$0.118	30 Nov -0001	30 Nov -0001	30 Nov -0001
27 Mar 2020	$0.0997	30 Nov -0001	30 Nov -0001	30 Nov -0001
27 Sep 2019	$0.0986	30 Nov -0001	30 Nov -0001	30 Nov -0001
28 Mar 2019	$0.0950	30 Nov -0001	30 Nov -0001	30 Nov -0001
27 Sep 2018	$0.0640	30 Nov -0001	30 Nov -0001	30 Nov -0001
28 Mar 2018	$0.0586	30 Nov -0001	30 Nov -0001	30 Nov -0001
02 Oct 2017	$0.0575	30 Nov -0001	30 Nov -0001	30 Nov -0001

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
RTMVY	Ex Dividend Knight	2023-09-28	Annually	0.00%
CNBA	Ex Dividend Knight	2023-08-15	Quarterly	0.00%
MCHB	Ex Dividend Knight	2023-08-09	Annually	0.00%
AMFC	Ex Dividend Knight	2023-08-31	Annually	0.00%
HKUOF	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
TELNY	Ex Dividend Knight	2023-10-19	Semi-Annually	0.00%
DITTF	Ex Dividend Knight	2023-09-28	Annually	0.00%
OLCLF	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
BKKPF	Ex Dividend Junior	2023-09-06	Annually	0.00%
JPNRF	Ex Dividend Junior	2023-09-28	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.174	1.500	6.51	9.77	[0 - 0.5]
returnOnAssetsTTM	0.0981	1.200	6.73	8.07	[0 - 0.3]
returnOnEquityTTM	0.122	1.500	9.76	10.00	[0.1 - 1]
payoutRatioTTM	0.310	-1.000	6.90	-6.90	[0 - 1]
currentRatioTTM	4.40	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	3.11	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.206	1.500	4.41	6.62	[0.2 - 2]
debtRatioTTM	0.0109	-1.500	9.82	-10.00	[0 - 0.6]
interestCoverageTTM	102.86	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	241.85	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	98.59	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.0130	-1.500	9.95	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.661	1.000	2.31	2.31	[0.2 - 0.8]
operatingProfitMarginTTM	0.228	1.000	7.45	7.45	[0.1 - 0.6]
cashFlowToDebtRatioTTM	5.67	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.563	0.800	9.58	7.66	[0.5 - 2]
Total Score				13.38

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	2.10	1.000	9.89	0	[1 - 100]
returnOnEquityTTM	0.122	2.50	9.84	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	98.59	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.0000875	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	241.85	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0.310	1.500	6.90	-6.90	[0 - 1]
pegRatioTTM	0.00208	1.500	-3.32	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.110	1.000	9.75	0	[0.1 - 0.5]
Total Score				6.47

Nippon Shinyaku Co., Ltd. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Nippon Shinyaku Co., Ltd.

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Switzerland, and internationally. The company operates through Pharmaceuticals and Functional Food segments. It offers drugs for urological diseases, inflammation and allergies, hematologic malignancies, cardiovascular and metabolic diseases, gastrointestinal disorders, and other diseases. The company's products include Zalutia for urinary disorder caused by benign prostatic; Eviprostat for prostatic hypertrophy; Bladderon for pollakisuria; Estracyt for prostate cancer; Cialis for erectile dysfunction; Vidaza for myelodysplastic syndrome; Cylocide for solid tumor and acute leukemia; CylocideN for relapsed and refractory acute leukemia and malignant lymphoma; Gazyva for humanized anti-CD20 monoclonal antibody; Defiterio sinusoidal obstruction syndrome; and Trisenox and Amnolake for relapsed and refractory acute promyelocytic leukemia. Nippon Shinyaku Co., Ltd.'s products also comprise Uptravi, Adcirca, and Opsumit for pulmonary arterial hypertension; VILTEPSO for muscular dystrophy; Lunabel LD and Lunabel ULD for dysmenorrhea; Erizas, a dry powder inhaler solution for allergic rhinitis; Azunol Gargle liquid, a gargling solution containing azulene; Isobide for oral osmotic diuresis/meniere's disease; Cephadol for vertigo; Livostin for allergic rhinitis and conjunctivitis; Regtect for maintaining alcohol abstinence; and Onetram and Tramal for cancer and chronic pain. In addition, it researches, develops, and markets drugs in the areas of gynecology, otorhinolaryngology, and orthopedics. Further, the company provides functional foods, such as health food ingredients, preservatives, protein preparations, supplements, and spice and condiments. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.